Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Lifestance Health Group stock hits 52-week high at $8.90 By Investing.com - Investing.com India
Lifestance Health Group stock hits 52-week high at $8.90 By Investing.comInvesting.com India
New India Assurance, Star Health, CDSL surge amid spike in trading activity; check full list - Upstox
New India Assurance, Star Health, CDSL surge amid spike in trading activity; check full listUpstox
New India Assurance Company Ltd leads gainers in 'A' group
Galaxy Surfactants Ltd, Star Health & Allied Insurance Company Ltd, FSN E-Commerce Ventures Ltd and R R Kabel Ltd are among the other gainers in the BSE's 'A' group today, 18 June 2026.
Volumes jump at Procter & Gamble Hygiene and Health Care Ltd counter
Procter & Gamble Hygiene and Health Care Ltd saw volume of 6.2 lakh shares by 10:47 IST on BSE, a 320.13 fold spurt over two-week average daily volume of 1937 shares
Stock Picks Today: Tata Motors PV, Shyam Metalics, Titan, Max Health, United Spirits, Thyrocare And More On Brokerages' Radar
Brokerages' Radar
India makes gains in child, maternal health but nutrition challenges persist: SBI report
India's latest health survey reveals significant improvements in maternal care and child vaccination rates. Stunting among children has seen a notable decline. However, modest gains in underweight and wasting indicate a need for comprehensive nutrition strategies. The survey also points to a rise in obesity among women. Fertility rates are stable, and women's financial inclusion has strengthened.
JM Fin on insurance: Retail health to drive growth; Star Health top pick
The brokerage said that it prefers Star Health in the space as it has recommended a 'Buy' rating on the stock for a target price of ₹650.
Public-private projects key to expand access to Kidney care: NephroPlus
NephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-based platform aimed at preventing chronic kidney disease. As it scales up its network of dialysis centers both domestically and in global markets, this forward-thinking initiative seeks to combat the advancement of kidney ailments.
Cipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026
Cipla said that its wholly owned subsidiary, Cipla Health, has appointed Shivam Puri as chief executive officer (CEO) of its One India Business and a member of the company's Management Council, effective 1 July 2026.
Fast-tracked power plants fuel AI boom, with little public scrutiny
New power plants are being built at an unprecedented speed to meet the growing demand of tech companies. These facilities, often fueled by natural gas, are being approved with minimal public notice and environmental review. Residents are raising alarms about potential health and climate impacts. This trend is reshaping energy infrastructure across the United States.
Pharma stocks edge lower after government tightens rules on cough syrup sales
Shares of select pharmaceutical companies traded lower on Tuesday after the Ministry of Health and Family Welfare tightened regulations governing the sale of cough syrups across the country.
Cipla appoints health chief Shivam Puri to lead One India business
Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take effect from July 1. Puri currently heads Cipla Health, a role he has held since 2019. His extensive experience in consumer goods and healthcare will now steer Cipla's domestic operations.